Table 1

Patient characteristics

ControlSepsis
N5353
PRMT4, mean (SD, ng/mL)7.8 (11.0)18.4 (28.6)
Demographics
 Age (years), mean (SD)55 (15.0)55 (17.5)
 Male, n (%)31 (58.5)24 (45.3)
 BMI, mean (SD)28.8 (9.1)30.9 (9.4)
Comorbidities, n (%)
 Diabetes16 (30.2)22 (41.5)
 COPD6 (11.3)11 (20.7)
 Immunosuppression9 (17)9 (17)
 Chronic cardiac failure3 (5.7)7 (13.2)
 Chronic kidney disease6 (11.3)5 (9.4)
 Pulmonary fibrosis0 (0)2 (3.8)
 Active neoplasm3 (5.7)3 (5.7)
 Chronic liver disease9 (17)6 (11.3)
 Alcohol use13 (24.5)8 (15.1)
Severity of Illness
 SOFA score,1 mean (SD)5.2 (2.4)7.4 (2.6)
 PaO2:FiO2 ratio, mean (SD)224 (152)196 (88)
 Shock, n (%)10 (18.9)34 (64.2)
 Acute kidney injury, n (%)22 (41.5)40 (75.5)
 ICU LOS (days), mean (SD)8.5 (9.4)13.4 (9.8)
 30-day mortality, n (%)6 (11.3)12 (22.6)
 90-day mortality, n (%)7 (13.2)13 (24.5)
  • BMI, body mass index; FiO2, fraction of inspired oxygen; ICU, intensive care unit; LOS, length of stay; PaO2, arterial partial pressure of oxygen; PRMT4, protein Aarginine N-methyltransferase 4; SOFA, sequential organ failure assessment.